Since the emergence of the COVID-19 pandemic, extensive studies have continued to explore the disease pathogenesis, as well as acquired and induced immunity against the infection. With the recent development and dissemination of COVID-19 vaccinations, cellular analysis of T and B cells has become crucial not only for patient monitoring, but also in evaluating the efficiency of immunization of candidate and established vaccines.
Working with these rare cells can prove challenging to researchers: critically low cell frequencies, inflammatory environments, unspecific labeling, and high levels of background noise often hamper reliable analysis. In this webinar, we will introduce solutions for the efficient and reproducible analysis of these cell types in SARS-CoV-2 research.
May 4, 2021
Berlin, Germany (GMT+02:00) − 7:00 PM CEST
San Francisco, CA, USA (GMT-07:00) − 10:00 AM PST
New York, NY, USA (GMT-04:00) − 1:00 PM EDT
May 6, 2021
Berlin, Germany (GMT+02:00) − 10:00 AM CEST
London, United Kingdom (GMT+01:00) − 9:00 AM GMT
Singapore, Singapore (GMT+08:00) − 4:00 PM
Cristina Conforti Andreoni
Webinar login information
1. To log in to the webinar, open your invitation or registration confirmation email, and then click the link to join the webinar. The webinar information page appears.
2. Enter your name and—if not automatically populated—your email address and the webinar password.
3. Click 'Join now' to be connected to the webinar.
4. Join the audio conference with your computer-connected headset or dial in with your telephone and your local WebEx telephone number provided.
Do you have further questions on log in, time zones, or topics scheduled? Contact us at MACS_Academy@miltenyibiotec.de
We recommend to use a computer or tablet with a connected headset or telephone.
Join a WebEx test meeting to check your system compatibility: http://www.webex.com/test-meeting.html